FIT-Based CRC Screening Program Associated With Decrease in Overall CRC Incidence
Investigators assessed the incidence of colorectal cancer and mortality rates following the application of a fecal immunochemical testing-based screening program.
Investigators assessed the incidence of colorectal cancer and mortality rates following the application of a fecal immunochemical testing-based screening program.
Weight loss from age 20 to ages 55-74 was linked to reduced adenoma risk, especially for those who were overweight or obese.
The excess risk of cancer appeared to be associated with the severity of heart failure.
The youngest adults have the greatest burden of distant-stage early-onset colorectal adenocarcinoma.
The absolute risk for overall cancer was 4.7% during the first year of follow-up.
The most common topics of tweets were early detection of disease, bereavement, and research.
Oxaliplatin did not prolong progression-free survival and was associated with more adverse events.
For patients aged 45 to 49 years, 32% had any neoplasia, 7.5% had advanced premalignant lesions, and 0.58% had colorectal cancer.
At 12 months, the cumulative incidence of major financial hardship was 71.3%.
About 97% of gastroenterologists chose colonoscopy as their preferred screening method.